Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
27.04
-0.24 (-0.88%)
Nov 21, 2024, 4:00 PM EST - Market closed
Q32 Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -60.61 | -53.74 | -42.81 | -37.56 |
| Depreciation & Amortization | 0.49 | 0.5 | 0.37 | 0.05 |
| Other Amortization | 0.18 | 0.09 | 0.1 | 0.1 |
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - |
| Stock-Based Compensation | 3.66 | 1.43 | 1.24 | 0.75 |
| Other Operating Activities | -16.52 | 6.74 | 3.18 | - |
| Change in Accounts Payable | -1.14 | 2.03 | -1.24 | 1.1 |
| Change in Unearned Revenue | -40.34 | -25.85 | 25.85 | - |
| Change in Other Net Operating Assets | 45.2 | 50.13 | 2.34 | 2.58 |
| Operating Cash Flow | -67 | -18.68 | -10.96 | -32.98 |
| Capital Expenditures | -0.07 | -0.01 | -2.49 | -0.16 |
| Sale of Property, Plant & Equipment | - | - | 0.02 | - |
| Investing Cash Flow | 19.93 | -0.01 | -2.47 | -0.16 |
| Long-Term Debt Issued | - | 5.5 | 30 | - |
| Long-Term Debt Repaid | - | -5.2 | - | - |
| Net Debt Issued (Repaid) | 51.44 | 0.3 | 30 | - |
| Issuance of Common Stock | 43.45 | 0.11 | 0.07 | 0.12 |
| Financing Cash Flow | 94.9 | 0.41 | 30.07 | 20.11 |
| Net Cash Flow | 47.82 | -18.28 | 16.65 | -13.03 |
| Free Cash Flow | -67.07 | -18.68 | -13.44 | -33.14 |
| Free Cash Flow Margin | - | - | -202.10% | - |
| Free Cash Flow Per Share | -5.06 | -2.58 | -1.91 | -5.12 |
| Levered Free Cash Flow | -71.27 | -40.9 | -8.73 | - |
| Unlevered Free Cash Flow | -70.63 | -40.67 | -8.83 | - |
| Change in Net Working Capital | 26.34 | 12.44 | -16.57 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.